Cancers in Chronic HIV Infection
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Infectious Agents and Cancer".
Deadline for manuscript submissions: closed (31 December 2025) | Viewed by 2271
Special Issue Editor
Special Issue Information
Dear Colleagues,
HIV increases the risk of developing cancer, and it has been considered a carcinogenic since 1996. The combination antiretroviral therapy (cART) and the subsequent immune restoration leads to a significant reduction in the incidence of AIDS-defining cancers in people with HIV (PWH); however, the incidence of cancer is still much higher in HIV patients than in the general population. In addition, non-AIDS-defining cancers (such as liver and anal cancers) are also increasing in number as a consequence of persistent immune system dysregulation, even after long-term virological suppression and a robust immune recovery.
Modern HIV pharmacology has successfully turned this deadly disease into a chronic condition. Cancers are becoming critical comorbidities in aging PWH due to concomitant infections with oncogenic viruses, accelerated aging, and higher prevalence of risk factors. Thus, HIV patients are exposed to infection-related and infection-unrelated cancers, as primary or secondary malignancies.
The aim of this Special Issue is to refocus the attention of healthcare providers, going beyond the undetectable viral load, reshaping clinical management, and supporting both proactive screening and preventive strategies. In this Special Issue of Cancers, we welcome original research articles or comprehensive reviews focusing on cancer risk, types of malignancies, pathogenesis, barriers in diagnosing, treatment disparities, treatment outcomes, and preventive strategies. We look forward to your submissions.
Dr. Diego Ripamonti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- HIV
- AIDS
- cancer screening
- hematologic malignancy
- Kaposi sarcoma
- HPV
- anal cancer
- lymphoma
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
